CURRENT OPINION IN PHARMACOLOGY

Current Opinion in Pharmacology (ISSN 1471-4892) is a distinguished bi-monthly journal published by Elsevier in the United Kingdom, widely recognized for its high impact factor and consistent placement in the top quartile of the pharmacology field according to the Chinese Academy of Sciences journal ranking. As a non-open access publication indexed in the Science Citation Index (SCI), the journal serves as a premier venue for authoritative, state-of-the-art reviews rather than original experimental research, focusing on synthesizing the latest advancements in drug discovery, pharmacodynamics, pharmacokinetics, toxicology, and clinical pharmacology. Its rigorous editorial standards and selective acceptance rate reflect a commitment to publishing high-quality, expert-driven perspectives that provide a comprehensive overview of current trends in the field. Consequently, the journal is particularly well-suited for senior researchers and established experts in pharmacology who aim to disseminate critical insights and authoritative opinions to a specialized academic audience, offering a reliable platform for shaping discourse in the discipline despite its limited capacity for primary data-driven studies.